or Try an Advanced Search...

    Technical Analysis for KZR - Kezar Life Sciences, Inc.

    Grade Last Price % Change Price Change
    C 7.21 -3.22% -0.24
    KZR closed down 3.22 percent on Friday, November 1, 2024, on 1.15 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    Earnings due: Nov 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical KZR trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Fell Below 20 DMA Bearish -3.22%
    Fell Below 200 DMA Bearish -3.22%
    1,2,3 Pullback Bullish Bullish Swing Setup -3.22%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.22%
    Inside Day Range Contraction -3.22%
    Gapped Down Weakness -3.22%
    50 DMA Support Bullish -11.97%
    Older End-of-Day Signals for KZR ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 200 DMA about 22 hours ago
    200 DMA Resistance about 22 hours ago
    Up 3% about 22 hours ago
    Up 2% about 22 hours ago
    Up 1% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    KZR Chart by TradingView
    Basic chart:

    Profile

    Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Pharmaceutical Autoimmunity Molecule Therapeutics Immunity

    Is KZR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 Looking Into Kezar Life Sciences's Recent Short Interest
    Oct 28 Kezar Life Sciences announces 1-for-10 reverse stock split
    Oct 28 Kezar Life Sciences Announces 1-for-10 Reverse Stock Split
    Oct 18 Kezar Life Sciences discontinues lupus nephritis programme after fatalities
    Oct 17 Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study
    Oct 17 Kezar stock falls 11% after board rejects Concentra offer (update)
    Oct 17 Kezar discontinues development of zetomipzomib for lupus nephritis
    Oct 17 Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan
    Oct 17 Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan
    Oct 17 Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update
    See more KZR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.35
    52 Week Low 5.202
    Average Volume 109,987
    200-Day Moving Average 7.53
    50-Day Moving Average 6.93
    20-Day Moving Average 8.06
    10-Day Moving Average 7.77
    Average True Range 0.61
    RSI (14) 40.48
    ADX 29.36
    +DI 14.68
    -DI 10.01
    Chandelier Exit (Long, 3 ATRs) 7.34
    Chandelier Exit (Short, 3 ATRs) 8.69
    Upper Bollinger Bands 9.02
    Lower Bollinger Band 7.10
    Percent B (%b) 0.06
    BandWidth 23.76
    MACD Line 0.14
    MACD Signal Line 0.32
    MACD Histogram -0.1751
    Fundamentals Value
    Market Cap 524.89 Million
    Num Shares 72.8 Million
    EPS -1.21
    Price-to-Earnings (P/E) Ratio -5.96
    Price-to-Sales 9.91
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.32
    Resistance 3 (R3) 8.37 8.06 8.14
    Resistance 2 (R2) 8.06 7.77 8.03 8.07
    Resistance 1 (R1) 7.63 7.60 7.48 7.58 8.01
    Pivot Point 7.32 7.32 7.24 7.29 7.32
    Support 1 (S1) 6.89 7.03 6.74 6.84 6.41
    Support 2 (S2) 6.58 6.86 6.55 6.35
    Support 3 (S3) 6.15 6.58 6.29
    Support 4 (S4) 6.10